Novartis India enters into Supply & Distribution Agreement with Themis Medicare

Novartis India Ltd. | Trading | Miscellaneous | BSE: 500672 | NSE: NOVARTIND

17 Sep 2013 Evaluate

Novartis India has entered into a Supply & Distribution Agreement with Themis Medicare on August 16, 2013. As per agreement, Themis has agreed to manufacture and supply and Novartis has agreed long term exclusive purchase from Themis Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form on certain commercial terms and conditions for Indian market.

Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.

Peers

Company Name	CMP
Redington	399.25
Adani Enterprises	2939.50
Amrapali Industries	37.80
Rashi Peripheral	888.65
ABans Enterprises	27.49
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.